On 19 August 2026, Mr. Yves Leterme and his delegation paid a formal visit to Taizhi Medical, engaging in constructive dialogue on Sino-European collaboration within the health consumer sector and market expansion across Europe. The visit has forged a valuable cross-border cooperation channel for Taizhi Medical’s international development and underpins long-term, mutually beneficial exchanges in the life sciences and everyday health consumer industries between China and Europe. 

A distinguished statesman and industry advocate, Mr. Yves Leterme has served two terms as Prime Minister of Belgium and held the role of Deputy Secretary-General at the Organisation for Economic Co-operation and Development (OECD) from 2011 to 2014. Widely recognised as a core hub for European biomedical innovation, Belgium hosts the Leuven Biotech Park, home to leading global enterprises including UCB and Janssen Pharmaceuticals, supported by a complete, mature industrial supply chain and professional service ecosystem.

Since leaving public office, Mr. Leterme has dedicated his practice to cross-border industrial consulting for Sino-European health sectors. He possesses authoritative expertise in EU market access compliance for daily protective equipment and plant-derived consumer goods. He has chaired multiple Sino-Belgian life science forums, focusing on cross-border trade optimisation and industrial resource alignment for health consumer products. For many years, he has served as a key bridge connecting governmental and industrial stakeholders in China and Europe, facilitating professional exchanges with domestic plant-based health enterprises and advancing diversified, synergistic development across the global health industry. 

Factory Visit & On-site Exchange

During the visit, the delegation toured Taizhi Medical’s intelligent production workshops and brand R&D exhibition areas. The team gained first-hand insight into the company’s end-to-end production workflows, independent product research and development capabilities, and rigorous standardised quality control systems for daily protective face masks. Both parties held in-depth discussions covering the current landscape of the Sino-European health consumer goods industry, the unique advantages of Sino-Belgian economic and trade cooperation, and emerging trends in global overseas market expansion, sharing practical industry experience and forward-looking cooperation perspectives. 

Industrial Symposium: Exploring EU Market Cooperation Opportunities 

Following the on-site tour, a dedicated industrial symposium was convened by both parties. Leveraging his extensive experience in European governance and international economic and trade cooperation, Mr. Leterme shared in-depth analysis on EU market access standards for daily protective products, proven strategies for building European distribution networks, and evolving consumer demands within Europe’s health and wellness market. 

The symposium has established a new, sustainable platform for international industrial dialogue. It creates favourable conditions for Taizhi Medical’s daily protective mask portfolio to enter the European market and expand global partnerships, while laying a solid foundation for regular industrial exchanges and commercial cooperation between Chinese and Belgian health industry players. 

To conclude the session, representatives from both sides participated in traditional Chinese calligraphy as a symbolic gesture of friendship, preserving the memorable moment of cross-border industrial collaboration. The joint commemoration embodies the shared aspiration of open communication, win-win cooperation and joint advancement for the Sino-European health consumer industry. 

Accelerating Globalisation & Empowering Overseas Development 

This high-level international industrial dialogue represents a pivotal milestone in Taizhi Medical’s globalisation strategy. Building on this newly established Sino-European cooperation mechanism, Taizhi Medical will continue to prioritise R&D innovation for daily protective products. The company will uphold dual compliance with domestic and EU industrial standards throughout production, accelerating the European market launch of its innovative plant-derived protective face mask series. 

Moving ahead, Taizhi Medical will further collaborate with global industry partners to expand its footprint in the international daily health consumer market. The company will continue to deepen cross-industry exchanges and pragmatic cooperation between China and Europe, contributing steady momentum to the high-quality, inclusive development of the worldwide health industry.